prostate

Mark Cuban pharmacy could save billions on prostate cancer, bladder drugs

Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs.

VISE team seeks to develop new robot to ease prostatectomies

The Vanderbilt Institute for Surgery and Engineering (VISE) team of Robert Webster III, PhD, and Duke Herrell, MD, have received a $2.2 million grant from the National Institutes of Health to develop a new surgical robot for endoscopic transurethral prostatectomy.

Sharing the stage

Legendary actor Ed Asner shared the stage with Vanderbilt’s Joseph (Jay) Smith Jr., M.D., at the Franklin Theatre Saturday night after Asner performed his sold-out show “A Man and His Prostate.”

My Southern Health: What to ask your doctor about prostate cancer screening

In 2012, the United States Preventive Services Task Force recommended that men of all ages should not be routinely screened for levels of prostate-specific antigen (PSA). That group now recommends that men ages 55 to 69 should talk with their doctors and make well-informed individual decisions about the potential harms and benefits of PSA screening, and treatment if cancer is found.

Douglas Milam, associate professor of urologic surgery at Vanderbilt University Medical Center, discusses what prostate issues might cause you trouble and what you can do about them.

My Southern Health: Common prostate ailments

Douglas Milam, associate professor of urologic surgery at Vanderbilt University Medical Center, discusses what prostate issues might cause you trouble and what you can do about them.